Next Biomedical Co.,Ltd. (KOSDAQ:389650)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Endoscopic Hemostatic Agent	8.26B
Vascular Embolic Microspheres	788.73M
Vascular Embolic Microspheres -F	489.21M
Other	8.40M

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Europe	4.40B
United States	4.39B
South Korea	676.12M
Other	68.96M

Data Source: Finnhub Last updated: Jun 30, 2026

Financial data is provided by Finnhub and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error